SUBSTRATE ANALOGS FOR DETECTION CHARACTERIZATION AND INHIBITION STUDIES OF ENZYMES ASSOCIATED WITH THE DNA REPLICATION OF VIRUSES AND CELLS NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


SUBSTRATE ANALOGS FOR DETECTION CHARACTERIZATION AND INHIBITION STUDIES OF ENZYMES ASSOCIATED WITH THE DNA REPLICATION OF VIRUSES AND CELLS

Diss Abstr Int [C]; 50(4):682 1989. Unique Identifier : AIDSLINE ICDB/90662079
Karlstrom AR; Uppsala Universitet, Sweden


Abstract: The biological synthesis of 5-[125I] iododeoxyuridine-monophosphate and triphosphate by enzymatic phosphorylation of 5-[125I] iododeoxyuridine and their subsequent purifications are described. The specificity and gain in sensitivity achieved with these substrates in enzyme assays is demonstrated. The increased sensitivities were exploited for the detection of viral enzyme activity-blocking antibodies (ab) in human sera. From studies on the immunological relationship between the TMPK and thymidine kinase (TK) induced by herpes simplex virus (HSV)-1 and HSV-2, it was concluded that the HSV-2, but not the HSV-1, TMPK and TK activities are mediated by different catalytic sites. The increased sensitivity of the reverse transcriptase (RT) assay made direct detection of human immunodeficiency virus (HIV)RT ab in patients possible. All sera from HIV infected individuals were found positive; however, the earlier reported relation between HIV RT ab amount and clinical status could not be verified. The improved measurement of TMPK for analysis of enzyme activity in tumor biopsies, as well as the use of the new DNA assay for serum analyses, is illustrated. The different forms of TK and DNAp found in sera from patients with leukemia, B12-deficiency and human cytomegalovirus infections were characterized with respect to mol wt. The major TK form found in serum had a mol wt of 730 kD which differed from that found in cells (58 kD). The large 730 kD form was shown to be quantitatively converted into the smaller 58 kD form in the presence of dithioerythriol (DTE) and exhibited the same kinetic behavior as the proliferation associated TK1 found in HeLa cells. The DNAp had an mol wt of 240 kD which was to converted into a smaller form (56 kD) in the presence of DTE. It was concluded that both TK and DNAp occur in other forms in serum than during catalytic conditions in vitro. Finally, the guanosine analogs--acyclovir, bucyclovir, ganciclovir, (S)-9-(3,4-dihydroxybutyl)guanine, 9-(4-hydroxybutyl)guanine and (RS)-9-(4-hydroxy-2-(hydroxymethyl)butyl) guanine--were compared in enzyme kinetic experiments on varicella zoster virus (VZV) TK and TK2. They were also compared in their efficacy in inhibiting VZV multiplication in cell culture.
Keywords: Deoxyuracil Nucleotides/METABOLISM *DNA Replication Guanine/ANALOGS & DERIVATIVES Hela Cells Human Idoxuridine/*METABOLISM Kinetics Molecular Weight Substrate Specificity Thymidine Kinase/*METABOLISM *Virus Replication THESISKWDdeoxyuracilnucleotides/metabolismKWDdnareplicationguanine/analogs&derivativeshelacellshumanidoxuridine/KWDmetabolismkineticsmolecularweightsubstratespecificitythymidinekinase/KWDmetabolismKWDvirusreplicationthesis
900630
M9060641

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .